Bicyclic compounds as NR2B receptor antagonists
OwnerKazuo Ando, Makoto Kawai +4inventors
InventorsKazuo Ando, Makoto Kawai, Mitsuhiro Kawamura, Miyako Matsumizu, Asato Morita, Isao Sakurada
Life of this patent
Estimating the term…
Loading patent…
OwnerKazuo Ando, Makoto Kawai +4inventors
InventorsKazuo Ando, Makoto Kawai, Mitsuhiro Kawamura, Miyako Matsumizu, Asato Morita, Isao Sakurada
Estimating the term…
This invention provides a compound of the formula (I): 1 wherein R1 and R2 independently represent a hydrogen atom or the like; X represents a covalent bond or the like: A represents a bicyclic, aromatic, saturated or partially unsaturated heterocyclic or carbocyclic group having from 8 to 12 ring atoms; or the like: B represents a phenyl group or a heteroaryl group having from 5 to 6 ring atoms or the like: These compounds are useful for the treatment of disease conditions caused by overactivation of NMDA NR2B receptor such of pain, or the like in mammalian. This invention also provides a pharmaceutical composition comprising the above compound.
A compound of the formula (I):
Dependencies are inferred from the claim text.